There was a sense of unprecedented urgency and anticipation May 17 at the Independent Cosmetic Manufacturers and Distributors’ FDA regulations workshop in New York, where attendees were put on notice about changes to the oversight framework that may be on the way.
Former FDA Cosmetics Director John Bailey, who serves ICMAD in a consulting capacity now, led off the day’s presentations, advising the organization’s members to pay close attention to current goings-on in Washington,
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?